{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:02:41Z","timestamp":1784044961957,"version":"3.55.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Cancer remains a major global health burden, and conventional treatments such as surgery, radiotherapy, and chemotherapy are often limited by systemic toxicity, drug resistance, and high cost. Anticancer peptides (ACPs) have emerged as promising therapeutic candidates because of their selective activity against tumor cells; however, experimental identification of ACPs is labor-intensive and time-consuming, and peptide activity may vary across tissue contexts. Although many computational models have been developed for general ACP prediction, tissue-specific ACP classification remains insufficiently explored. In this study, we developed ACP-Boost, a tissue-aware machine learning framework for tissue-specific ACP classification across nine cancer-related tissues: blood, brain, breast, cervix, colon, liver, lung, prostate, and skin. Experimentally validated peptide records were integrated from CancerPPD2 and DCTPep, followed by preprocessing, redundancy control, and tissue annotation. Peptide sequences were encoded into 473-dimensional feature vectors comprising amino acid composition (AAC), dipeptide composition (DPC), physicochemical property composition (PCP), and pseudo-amino acid composition (PseAAC). To address class imbalance while preserving the original sequence distribution, we formulated the task as a one-versus-rest classification problem, applied group-aware train-test splitting based on peptide sequences, and emphasized evaluation metrics suitable for imbalanced data. We systematically compared five machine learning algorithms, including support vector machine, random forest, logistic regression, k-nearest neighbors, and XGBoost. Among them, XGBoost showed the most stable overall performance across tissues. The results indicate that peptide sequence-derived descriptors contain measurable tissue-associated signals, although predictive separability remains moderate for several cancer types. Feature importance analysis further suggested that both shared charge-related properties and tissue-dependent sequence descriptors contribute to model discrimination. Overall, this study provides a comparative computational framework for tissue-specific ACP classification and highlights the importance of incorporating biological heterogeneity into peptide prediction tasks.<\/jats:p>","DOI":"10.3389\/fmolb.2026.1815309","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:33:48Z","timestamp":1774506828000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative analysis of tissue-specific anticancer peptide prediction models: ACP-Boost framework"],"prefix":"10.3389","volume":"13","author":[{"given":"Ruizhe","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, The First Clinical College of Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichen","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, The First Clinical College of Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, The First Clinical College of Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, China"]},{"name":"Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, The First Clinical College of Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"bbaa153","DOI":"10.1093\/bib\/bbaa153","article-title":"AntiCP 2.0: an updated model for predicting anticancer peptides","volume":"22","author":"Agrawal","year":"2021","journal-title":"Brief. Bioinform"},{"key":"B2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1139\/bcb-2016-0175","article-title":"Anticancer activities of bovine and human lactoferricin-derived peptides","volume":"95","author":"Arias","year":"2017","journal-title":"Biochem. Cell Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.2174\/1389203721666200117171403","article-title":"Evolution of machine learning algorithms in the prediction and design of anticancer peptides","volume":"21","author":"Basith","year":"2020","journal-title":"Curr. Protein Pept. Sci."},{"key":"B4","first-page":"281","article-title":"Random search for hyper-parameter optimization","volume":"13","author":"Bergstra","year":"2012","journal-title":"J. Machine Learning Research"},{"key":"B5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca-a Cancer J. Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","year":"2001","journal-title":"Mach. LEARN"},{"key":"B7","first-page":"3121","article-title":"The balanced accuracy and its posterior distribution","author":"Brodersen","year":"2010"},{"key":"B8","doi-asserted-by":"publisher","first-page":"baaf030","DOI":"10.1093\/database\/baaf030","article-title":"CancerPPD2: an updated repository of anticancer peptides and proteins","volume":"2025","author":"Chauhan","year":"2025","journal-title":"Database (Oxford)"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1145\/2939672.2939785","volume-title":"XGBoost: a scalable tree boosting system","author":"Chen","year":"2016"},{"key":"B10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3892\/ijo.2020.5099","article-title":"Anticancer peptide: physicochemical property, functional aspect and trend in clinical application","volume":"57","author":"Chiangjong","year":"2020","journal-title":"Int. J. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","article-title":"The advantages of the matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation","volume":"21","author":"Chicco","year":"2020","journal-title":"BMC Genomics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"114996","DOI":"10.1016\/j.biopha.2023.114996","article-title":"Current research status of anti-cancer peptides: mechanism of action, production, and clinical applications","volume":"164","author":"Chinnadurai","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/prot.1035","article-title":"Prediction of protein cellular attributes using pseudo-amino acid composition","volume":"43","author":"Chou","year":"2001","journal-title":"Proteins"},{"key":"B14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/bf00994018","article-title":"Support-vector networks","volume":"20","author":"Cortes","year":"1995","journal-title":"Mach. Learn."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8700","DOI":"10.1073\/pnas.92.19.8700","article-title":"Prediction of protein folding class using global description of amino acid sequence","volume":"92","author":"Dubchak","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1613\/jair.1.11192","article-title":"SMOTE for learning from imbalanced data: progress and challenges, marking the 15-year anniversary","volume":"61","author":"Fern\u00e1ndez","year":"2018","journal-title":"J. Artificial Intelligence Research"},{"key":"B17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/ijms20081997","article-title":"Pigment nephropathy: novel insights into inflammasome-mediated pathogenesis","volume":"20","author":"Giuliani","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1038\/s41598-022-09954-8","article-title":"On evaluation metrics for medical applications of artificial intelligence","volume":"12","author":"Hicks","year":"2022","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-Origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1010669","DOI":"10.1371\/journal.pcbi.1010669","article-title":"Ten quick tips for sequence-based prediction of protein properties using machine learning","volume":"18","author":"Hou","year":"2022","journal-title":"PLoS Comput. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/bioinformatics\/bts238","article-title":"Statistical interpretation of machine learning-based feature importance scores for biomarker discovery","volume":"28","author":"Huynh-Thu","year":"2012","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s11658-022-00332-w","article-title":"Anti-cancer peptide-based therapeutic strategies in solid tumors","volume":"27","author":"Karami Fath","year":"2022","journal-title":"Cell Mol. Biol. Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s43556-025-00352-w","article-title":"Drug resistance in cancer: molecular mechanisms and emerging treatment strategies","volume":"6","author":"Li","year":"2025","journal-title":"Mol. Biomed."},{"key":"B26","doi-asserted-by":"publisher","first-page":"bbaa312","DOI":"10.1093\/bib\/bbaa312","article-title":"Large-scale comparative review and assessment of computational methods for anti-cancer peptide identification","volume":"22","author":"Liang","year":"2021","journal-title":"Brief. Bioinform"},{"key":"B27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"B28","volume-title":"Impact of intrinsic and extrinsic factors on the pharmacokinetics of peptides: when is the assessment of certain factors warranted?","author":"Mahmood","year":"2021"},{"key":"B29","doi-asserted-by":"publisher","first-page":"77121","DOI":"10.18632\/oncotarget.20365","article-title":"MLACP: machine-learning-based prediction of anticancer peptides","volume":"8","author":"Manavalan","year":"2017","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.actbio.2021.03.056","article-title":"Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis","volume":"127","author":"Meng","year":"2021","journal-title":"Acta Biomater."},{"key":"B31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/neuonc\/nov164","article-title":"Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma","volume":"18","author":"Oberoi","year":"2016","journal-title":"Neuro Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.3168\/jds.2013-7285","article-title":"Bovine lactoferricin B induces apoptosis of human gastric cancer cell line AGS by inhibition of autophagy at a late stage","volume":"96","author":"Pan","year":"2013","journal-title":"J. Dairy Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1089\/cmb.2022.0241","article-title":"Pfeature: a tool for computing wide range of protein features and building prediction models","volume":"30","author":"Pande","year":"2023","journal-title":"J. Comput. Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00005-015-0359-5","article-title":"The role of cathelicidin LL-37 in cancer development","volume":"64","author":"Piktel","year":"2016","journal-title":"Arch. Immunol. Ther. Exp. Warsz."},{"key":"B35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chemphyslip.2011.09.004","article-title":"Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs","volume":"164","author":"Riedl","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"B36","first-page":"101","article-title":"In defense of one-vs-all classification","volume":"5","author":"Rifkin","year":"2004","journal-title":"J. Machine Learning Research"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2174\/138920111796117300","article-title":"Anti-angiogenic peptides for cancer therapeutics","volume":"12","author":"Rosca","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0118432","DOI":"10.1371\/journal.pone.0118432","article-title":"The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets","volume":"10","author":"Saito","year":"2015","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10555-024-10237-z","article-title":"Neuropeptide Y in cancer-biological functions and potential clinical implications","volume":"44","author":"Sigorski","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41597-024-03388-9","article-title":"DCTPep, the data of cancer therapy peptides","volume":"11","author":"Sun","year":"2024","journal-title":"Sci. Data"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1016\/j.csbj.2022.07.043","article-title":"MLACP 2.0: an updated machine learning tool for anticancer peptide prediction","volume":"20","author":"Thi Phan","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"D837","DOI":"10.1093\/nar\/gku892","article-title":"CancerPPD: a database of anticancer peptides and proteins","volume":"43","author":"Tyagi","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.04.025","article-title":"ACP-DL: a deep learning long short-term memory model to predict anticancer peptides using high-efficiency feature representation","volume":"17","author":"Yi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fonc.2024.1463088","article-title":"From defense to offense: antimicrobial peptides as promising therapeutics for cancer","volume":"14","author":"Zare-Zardini","year":"2024","journal-title":"Front. Oncol."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1815309\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:33:52Z","timestamp":1774506832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1815309\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":45,"alternative-id":["10.3389\/fmolb.2026.1815309"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1815309","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"article-number":"1815309"}}